| Field | Specification |
|---|---|
| Target | |
| Alternative names | Hamp ELISA Kit; Hamp1 ELISA Kit; Hepc ELISA Kit; Hepc1 ELISA Kit; Hepcidin ELISA Kit |
| UniProt # | |
| Species | |
| Reactivity | |
| Applications | |
| Assay type | |
| Sample type(s) | serum, plasma, tissue homogenates |
| Sensitivity | |
| Detection range | |
| Detection wavelength | |
| Assay time | |
| Catalog no. (Mfr.) | |
| Main SKU |
Background
hepcidin(Hepc) (HAMP) is a biological molecule commonly studied in cardiovascular research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: Q9EQ21
Biological context
Researchers often monitor hepcidin(Hepc) in serum, plasma, and tissue homogenates to better understand themes such as vascular biology and endothelial function, cardiac remodeling and injury responses, and thrombosis and hemostasis. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in hepcidin(Hepc) may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, endothelial markers, coagulation-related proteins, and cardiac injury markers) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, hepcidin(Hepc) may also appear under names such as Hamp and Hamp1. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that hepcidin(Hepc) participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
HIF-PHD inhibitor desidustat ameliorates iron deficiency anemia
VJ Patel, A Joharapurkar, SG Kshirsagar, MS Patel, HH Savsani, HS Dodiya, MH Rakhasiya,Toxicology and Applied Pharmacology,2024
Social defeat stress impairs systemic iron metabolism by activating the hepcidin–ferroportin axis
E Kasahara,FASEB BioAdvances,2024
Differences in DNA methylation of HAMP in blood cells predicts the development of type 2 diabetes
M Ouni,Molecular metabolism,2023
VHL-recruiting PROTAC attenuates renal fibrosis and preserves renal function via simultaneous degradation of Smad3 and stabilization of HIF-2α
J Yang,Cell & bioscience,2022
Hepcidin inhibition improves iron homeostasis in ferrous sulfate and LPS treatment model in mice
V Patel,Drug research,2021
Pharmacological inhibition of prolyl hydroxylase protects against inflammation-induced anemia via efficient erythropoiesis and hepcidin downregulation
Jain M, et al,European journal of pharmacology,2018
Hepatocyte toll-like receptor 4 mediates lipopolysaccharide-induced hepcidin expression
Yong-Soo Lee,et al,Experimental & Molecular Medicine,2017
Pharmacological Characterization of ZYAN1, a Novel Prolyl Hydroxylase Inhibitor for the Treatment of Anemia.
Jain MR.et al,Drug Res (Stuttg).,2016